أعرض في EDS

Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009

التفاصيل البيبلوغرافية
العنوان: Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009
المؤلفون: Cutsem, E. Van, Dicato, M., Arber, N., Berlin, J., Cervantes, A., Ciardiello, F., Gramont, A. De, Diaz-Rubio, E., Ducreux, M., Geva, R., Glimelius, B., Glynne-Jones, R., Grothey, Axel, Gruenberger, T., Haller, D., Haustermans, K., Labianca, R., Lenz, H. J., Minsky, B., Nordlinger, B., Ohtsu, A., Pavlidis, Nicholas, Rougier, P., Schmiegel, W., Velde, C. Van de, Schmoll, H. J., Sobrero, A., Tabernero, Josep
المساهمون: Pavlidis, Nicholas [0000-0002-2195-9961]
المصدر: Annals of Oncology : Official Journal of the European Society for Medical Oncology / ESMO
بيانات النشر: Elsevier BV, 2010.
سنة النشر: 2010
مصطلحات موضوعية: Oncology, Colorectal cancer, medicine.medical_treatment, Braf protein, Gastroenterology, Metastasis, Drug antagonism, Targeted therapy, Antineoplastic agents, Pathology, Conference paper, Biological markers, Predictive marker, Hematology, Prognosis, Chemotherapy regimen, Antineoplastic agent, Proto-oncogene proteins, Ras protein, Human, Receptor, medicine.medical_specialty, Neoplasm metastasis, Ras proteins, MEDLINE, Oncoprotein, Colorectal neoplasms, Proto-oncogene proteins b-raf, Internal medicine, Genetics, medicine, Humans, Gastrointestinal cancer, Colorectal tumor, B raf kinase, Epidermal growth factor receptor, Kras protein, business.industry, Epidermal growth factor, Cancer, medicine.disease, digestive system diseases, Biological marker, Metabolism, Spain, Mutation, Carcinoembryonic antigen, Microsatellite instability, business
الوصف: The article summarizes the expert discussion and recommendations on the use of molecular markers and of biological targeted therapies in metastatic colorectal cancer (mCRC), as well as a proposed treatment decision strategy for mCRC treatment. The meeting was conducted during the 11th ESMO/World Gastrointestinal Cancer Congress (WGICC) in Barcelona in June 2009. The manuscript describes the outcome of an expert discussion leading to an expert recommendation. The increasing knowledge on clinical and molecular markers and the availability of biological targeted therapies have major implications in the optimal management in mCRC. 21 Suppl 6 vi1 10
تدمد: 0923-7534
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbacd7b9ee1ebf6fa145eb7d60aaa564Test
https://doi.org/10.1093/annonc/mdq273Test
حقوق: OPEN
رقم الانضمام: edsair.doi.dedup.....cbacd7b9ee1ebf6fa145eb7d60aaa564
قاعدة البيانات: OpenAIRE
الوصف
تدمد:09237534